New combo attack on brain tumors shows promise
NCT ID NCT02858869
Summary
This small, early-stage study tested the safety of combining two treatments for cancer that has spread to the brain: an immunotherapy drug (pembrolizumab) and a very precise form of radiation (stereotactic radiosurgery). The goal was to see if using them together was safe and could better control brain tumors in patients with melanoma or non-small cell lung cancer. Researchers tested three different doses of radiation alongside the drug in 25 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM IN THE BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.